You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
濟民製藥(603222.SH):邵品擬回購公司所持新友誼醫院84.49%股權
格隆匯 12-09 21:35

格隆匯12月9日丨濟民製藥(603222.SH)公佈,此前,公司於2018年4月公司以人民幣1.15億元的對價收購新友誼醫院51%的股權,由於新友誼醫院2018年、2019年兩年承諾業績未達預期,已向公司以0元價格補償新友誼醫院33.49%股權,現公司持有新友誼醫院84.49%的股權。

鑑於新友誼醫院業績未達預期,公司將與邵品簽署《股權回購協議》,邵品回購公司持有新友誼醫院84.49%股權。本次股權回購價款由三部分組成,即甲方持有標的股權的投資本金+以甲方持有標的股權的投資本金為基數按照同期銀行貸款基準利率的2倍計算的資金佔用利息-甲方從目標公司收到的分紅,回購價款合計人民幣1.32億元整。本次交易完成後,公司不再持有新友誼醫院股權。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account